BIOGRAPHICAL SKETCH OF 2011-2012 RESIDENTS
PGY-1 Pharmacy Residents
Jeremy Sen, PharmD
(Email: jeremy.m.sen@virginia.edu)
Dr. Sen received his Doctor of Pharmacy in 2011 from the University of North Carolina
Eshelman School of Pharmacy in Chapel Hill, NC. His current area of interest is
hematology/oncology. Dr. Sen will complete a medication use evaluation attempting to elucidate
prescribing patterns and financial outcomes with the use of intravitreal ranibizumab and
bevacizumab for the treatment of neovascular (wet) age-related macular degeneration. His
residency project will evaluate pentoxifylline in the mitigation of amphotericin B nephrotoxicity.
Upon completion of the PGY-1 Pharmacy Residency, Dr. Sen plans to pursue a PGY-2
Oncology Pharmacy Residency at a tertiary care academic medical center.
Phillip Mohorn, PharmD
(Email: pm5wd@virginia.edu)
Dr. Mohorn is a graduate of the University of Georgia College of Pharmacy in Athens, GA
where he earned his PharmD degree in 2011. His current areas of interest include critical care
and emergency medicine. Dr. Mohorn’s medication use evaluation will evaluate the use of
tranexamic acid for total hip and knee arthroplasty at UVaHS. His research project will evaluate
the timing of antibiotic administration pre- and post-evening clinical pharmacist services which
may help identify areas for improvement in the sepsis related mortality index at UVaHS. Upon
completion of the PGY-1 pharmacy residency, he plans to pursue a PGY-2 residency within a
tertiary care academic medical center.
Kyle Luedtke, PharmD
(Email: kl5rm@virginia.edu)
Dr. Luedtke is a graduate of the Mercer University College of Pharmacy and Health Sciences in
Atlanta, Georgia, where she earned her PharmD degree in 2011. Her current areas of interest
include critical care and infectious diseases. Dr. Luedtke’s residency project will evaluate offlabel prescribing in a children’s rehabilitation center at UVaHS. Her medication use evaluation
will evaluate adherence to UVaHS venous thromboembolic prophylaxis guidelines among high
risk patients. Upon completion of the PGY-1 pharmacy residency, she plans to pursue a PGY-2
residency within a tertiary care academic medical center.
Carrie Hall, PharmD
(Email: ch3hy@virginia.edu)
Dr. Hall is a graduate of the University of Texas College of Pharmacy in Austin, TX, where she
earned her PharmD in 2011. Her current areas of interest include hematology/oncology,
palliative care, and ambulatory care. Dr. Hall’s medication use evaluation will evaluate the cost
and appropriateness of the use of echinocandins in the pediatric population at UVaHS. Her
research project will analyze the differences in clinical outcomes between two UVaHS insulin
infusion protocols used in diabetic patients, how staff are adhering to these policies, and whether
changes need to be made in the protocols. Upon completion of the PGY-1 pharmacy residency,
she plans to pursue a PGY-2 residency within a tertiary care academic medical center.
PGY-2 Critical Care Pharmacy Residents
Wennie Huang, PharmD
(Email: wh6w@virginia.edu)
Dr. Huang is a graduate of the University of Southern California School of Pharmacy in Los
Angeles, California, where she earned her PharmD degree in 2010. She completed a PGY-1
Pharmacy Residency at UMass Memorial Medical Center in June 2011. Her current areas of
interest are critical care and emergency medicine. Dr. Huang’s medication use evaluation will
assess the use of intravenous acetaminophen and her residency project will evaluate the clinical
outcomes and adverse effects of using high dose acyclovir for HSV encephalitis. Upon the
completion of her PGY-2 residency, Dr. Huang hopes to obtain a specialist position in critical
care or emergency medicine at an academic medical center.
Kate Bidwell, PharmD
(Email: klb2cp@virginia.edu)
Dr. Bidwell earned her PharmD from the Medical College of Virginia/Virginia Commonwealth
University in Richmond, Virginia in 2010 and completed a PGY-1 pharmacy residency at The
Ohio State University Medical Center in Columbus, Ohio in June 2011. Her current areas of
interest include critical care and emergency medicine. Dr. Bidwell’s medication use evaluation
will evaluate the dosing and adverse effects of dexmedetomidine in intensive care unit patients.
Her residency project will assess the safety and efficacy of a non-paralytic based anti-shivering
protocol used to control the autonomic shivering response in patients undergoing therapeutic
hypothermia for out-of-hospital cardiac arrest. Upon completion of the PGY-2 critical care
specialty residency, Dr. Bidwell plans to work as a critical care clinical specialist and pharmacy
educator.
PGY-2 Health System Pharmacy Administration Resident
Abby Reeder, PharmD
(Email: alr4x@virginia.edu)
Dr. Reeder is a 2010 graduate of Temple University School of Pharmacy in Philadelphia, PA.
She completed her pharmacy practice residency at Penn State Milton S. Hershey Medical Center
in Hershey, PA. Her interests include finance, operations, and long walks on the beach. For her
medication use evaluation, Dr. Reeder will be evaluating the increased costs associated with
pantoprazole and restriction non-adherence. Her longitudinal project will be assessing work flow
and customer satisfaction pre and post implementation of new technologies in the outpatient
pharmacy, Barringer Pharmacy. Upon completion of her PGY-2 in Health System Pharmacy
Administration, Dr. Reeder plans to pursue an MBA, drink lots of coffee, and work in pharmacy
administration.
PGY-2 Drug Information Resident
Geralyn Waters, PharmD
(Email: gw7t@virginia.edu)
Dr. Waters received a Bachelor of Music with a double-major in Spanish from Butler University
prior to completing a PharmD degree at the Massachusetts College of Pharmacy & Health
Sciences in 2010. The following year she completed a PGY-1 Pharmacy Residency at Virginia
Commonwealth University Health System. Current areas of interest include medication
management and safety. Dr. Waters’s longitudinal residency project will involve assessing drug
shortages, quantifying the impact on delivery of care, and measuring budgetary effects. In
addition, Dr. Waters is performing a medication utilization evaluation on dabigatran use. Upon
completion of the PGY-2 Drug Information Pharmacy Residency, Dr. Waters will pursue a
career as drug information specialist at a tertiary care academic medical center where she hopes
to have an opportunity to precept students and residents as well as teach as adjunct faculty at a
college of pharmacy.
PGY-2 Oncology Pharmacy Resident
Nicole Watts, PharmD
(Email: nlw8q@virginia.edu)
Dr. Watts is a graduate of the University of North Carolina-Chapel Hill Eshelman School of
Pharmacy in Chapel Hill, North Carolina, where she earned her PharmD degree in 2010. She
completed a PGY-1 Pharmacy Residency at the University of Virginia Health System. Dr.
Watts’s residency project will explore methods to reduce chemotherapy wait times in the Emily
Couric Clinical Cancer Center by identifying patients for which chemotherapy can be
compounded in advance and assessing the impact of this intervention on patient satisfaction.
Upon completion of her PGY-2 residency, Dr. Watts hopes to obtain a specialist position in
oncology at a tertiary care hospital. Her long-term goal is to practice as a clinical specialist in a
teaching hospital with the opportunity to precept students and residents.
PGY-2 Pharmacy Informatics Resident
Scott Vincent Anderson, PharmD, MS
(Email: sa4zg@virginia.edu)
Dr. Anderson is a graduate of University of Illinois at Chicago College of Pharmacy, where he
earned his PharmD degree in May 2010. The following year he was a PGY-1 Pharmacy Practice
Management Resident at the University of Pittsburgh Medical Center, during which he also
earned his MS in Health System Pharmacy Administration. His current interests include
automation technology and optimization of electronic medical records. Dr. Anderson’s residency
project will involve the implementation of a streamlined medication administration process using
a single access point for clinical nursing activities. The goal of this project is to assess the impact
on nurse efficiency and satisfaction post-implementation. Upon completion of the PGY-2
residency, Dr. Anderson plans to continue in a career focusing on the expansion of pharmacy
automation, development of pharmacy informatics programs, and interdisciplinary IT project
management.